Created in collaboration with physicians, for physicians, CancerRx is the first mobile app to aggregate and contextualize the world’s knowledge of genomics-based medicine in oncology. It provides guidance at the point of care for the latest cancer treatment options. By combining state–of-the-art genomic knowledge, insights from the nation’s top cancer experts and award winning product design, we created this unique and easy-to-use decision support tool for use in cancer treatment planning.

In addition to treatment guidance, CancerRx provides the most up-to-date information on which molecular tests should be considered for specific cancer types. Based on the results of those tests, the app will guide physicians in their evaluation of therapy options, including approved and investigationaldrugs and clinical trials.

CancerRx is the result of a joint effort between CollabRx and MedPage Today.

Key benefits:
· No cost, “beyond guidelines” decision support tool
· Accessible anytime, anywhere
· On demand detailed drug information
· Content vetted by nation’s leading experts in genomic-based cancer therapy
· Constantly updated data, treatment algorithms and news

Key features:
· Therapy Finders covering four of the major types of cancer are available at launch: breast cancer, lung cancer, melanoma and colorectal cancer. Additional Therapy Finders for other common cancer types will be released later this year.
· Presentation of clinical scenarios where current standard of care guidelines are relevant and access to “beyond guidelines" or investigational therapy options
· Individualized patient treatment options
· Access to daily, peer-reviewed news coverage
· Access to insights from renowned experts in the field of genomic medicine and oncology

CollabRx is the recognized leader in cloud-based expert systems to inform therapeutic decision making in oncology.

Medpage Today a subsidiary of Everyday Health Inc., is dedicated to improving the practice of medicine by providing health care practitioners with the latest medical news, practical tools and educational resources.